ACIP Backs Transition To Bivalent COVID-19 Vaccine, Flexibility On Number Of Annual Doses

The CDC panel supports transition away from the monovalent vaccine to simplify the schedule and reduce errors, but says more data is needed. Members disagree on whether children will need a primary series and favor the option for older adults and the immunocompromised to be vaccinated twice a year.